CN101259110A - 多层给药系统滴丸剂、其制备方法和装置 - Google Patents
多层给药系统滴丸剂、其制备方法和装置 Download PDFInfo
- Publication number
- CN101259110A CN101259110A CNA200710085959XA CN200710085959A CN101259110A CN 101259110 A CN101259110 A CN 101259110A CN A200710085959X A CNA200710085959X A CN A200710085959XA CN 200710085959 A CN200710085959 A CN 200710085959A CN 101259110 A CN101259110 A CN 101259110A
- Authority
- CN
- China
- Prior art keywords
- drug delivery
- delivery system
- drop pill
- layer
- feed liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000006187 pill Substances 0.000 title claims abstract description 56
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 238000012377 drug delivery Methods 0.000 title claims description 21
- 239000007788 liquid Substances 0.000 claims abstract description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 239000000758 substrate Substances 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 14
- 230000004927 fusion Effects 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 8
- -1 encapsulation Substances 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 2
- 238000005538 encapsulation Methods 0.000 claims description 2
- 239000002502 liposome Substances 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 150000002334 glycols Chemical class 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 26
- 229940079593 drug Drugs 0.000 abstract description 11
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 239000011159 matrix material Substances 0.000 abstract description 3
- 239000010410 layer Substances 0.000 abstract 10
- 239000002356 single layer Substances 0.000 abstract 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 10
- 238000000465 moulding Methods 0.000 description 8
- 238000012856 packing Methods 0.000 description 8
- 238000012216 screening Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 6
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- 239000007962 solid dispersion Substances 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000008118 PEG 6000 Substances 0.000 description 4
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 235000010603 pastilles Nutrition 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000003405 delayed action preparation Substances 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 229960000715 nimodipine Drugs 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229960000278 theophylline Drugs 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- PPWLAQVKIFDULF-UHFFFAOYSA-N 2-phenyl-1h-pyrrolo[2,3-b]pyridine Chemical compound N1C2=NC=CC=C2C=C1C1=CC=CC=C1 PPWLAQVKIFDULF-UHFFFAOYSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 1
- 241000005787 Cistanche Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000007766 cera flava Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960001699 ofloxacin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
- 229960003056 phentolamine mesylate Drugs 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710085959XA CN101259110B (zh) | 2007-03-06 | 2007-03-06 | 多层给药系统滴丸剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710085959XA CN101259110B (zh) | 2007-03-06 | 2007-03-06 | 多层给药系统滴丸剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101259110A true CN101259110A (zh) | 2008-09-10 |
CN101259110B CN101259110B (zh) | 2012-01-04 |
Family
ID=39959944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200710085959XA Active CN101259110B (zh) | 2007-03-06 | 2007-03-06 | 多层给药系统滴丸剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101259110B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101744721A (zh) * | 2008-12-03 | 2010-06-23 | 天津天士力制药股份有限公司 | 滴盘、滴制蓄料器单元、冷凝单元及其组成的装置单元和系统 |
CN102578443A (zh) * | 2011-12-28 | 2012-07-18 | 上海统益生物科技有限公司 | 一种制备可得然胶圆形凝胶粒的设备 |
CN105616164A (zh) * | 2016-03-30 | 2016-06-01 | 深圳万和制药有限公司 | 多层滴丸剂设备及其部件和多层滴丸剂的制备工艺 |
CN106333860A (zh) * | 2016-09-16 | 2017-01-18 | 深圳万和制药有限公司 | 改善多层滴丸结构的方法和其使用的设备 |
CN106924046A (zh) * | 2017-04-24 | 2017-07-07 | 中国科学技术大学 | 载药胶囊制备喷头和载药胶囊制备装置 |
CN109481440A (zh) * | 2018-12-29 | 2019-03-19 | 山东众鼎嘉成医药科技有限公司 | 硝苯地平在治疗中、重度高血压药品中的应用 |
CN112535704A (zh) * | 2020-12-10 | 2021-03-23 | 王雪克 | 一种降血糖药物组合物制备工艺 |
-
2007
- 2007-03-06 CN CN200710085959XA patent/CN101259110B/zh active Active
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101744721A (zh) * | 2008-12-03 | 2010-06-23 | 天津天士力制药股份有限公司 | 滴盘、滴制蓄料器单元、冷凝单元及其组成的装置单元和系统 |
CN101744721B (zh) * | 2008-12-03 | 2013-09-11 | 天士力制药集团股份有限公司 | 滴盘、滴制蓄料器单元、冷凝单元及其组成的装置单元和系统 |
CN102578443A (zh) * | 2011-12-28 | 2012-07-18 | 上海统益生物科技有限公司 | 一种制备可得然胶圆形凝胶粒的设备 |
CN105616164A (zh) * | 2016-03-30 | 2016-06-01 | 深圳万和制药有限公司 | 多层滴丸剂设备及其部件和多层滴丸剂的制备工艺 |
CN105616164B (zh) * | 2016-03-30 | 2019-05-31 | 深圳万和制药有限公司 | 多层滴丸剂设备及其部件和多层滴丸剂的制备工艺 |
CN106333860A (zh) * | 2016-09-16 | 2017-01-18 | 深圳万和制药有限公司 | 改善多层滴丸结构的方法和其使用的设备 |
CN106333860B (zh) * | 2016-09-16 | 2021-10-19 | 深圳万和制药有限公司 | 改善多层滴丸结构的方法和其使用的设备 |
CN106924046A (zh) * | 2017-04-24 | 2017-07-07 | 中国科学技术大学 | 载药胶囊制备喷头和载药胶囊制备装置 |
CN109481440A (zh) * | 2018-12-29 | 2019-03-19 | 山东众鼎嘉成医药科技有限公司 | 硝苯地平在治疗中、重度高血压药品中的应用 |
CN112535704A (zh) * | 2020-12-10 | 2021-03-23 | 王雪克 | 一种降血糖药物组合物制备工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN101259110B (zh) | 2012-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101259110B (zh) | 多层给药系统滴丸剂及其制备方法 | |
JP6586477B2 (ja) | 複数相軟質ゲル・カプセル、その装置及び方法 | |
US20210052500A1 (en) | Multiparticulate formulations of cannabinoids | |
US6596308B2 (en) | Controlled release pharmaceutical composition | |
US6491950B1 (en) | Controlled release pharmaceutical composition | |
EP2279729B1 (en) | Controlled release preparations | |
KR100887034B1 (ko) | 부틸프탈라이드 자가 에멀젼화 약물 전달 시스템, 그 제조방법 및 응용 | |
CN105395492B (zh) | 一种挥发油固体自乳化片剂及其制备方法 | |
CN102036654A (zh) | 稳定的非典型抗精神病制剂 | |
CN101022786A (zh) | 用自乳化制剂释放亲脂性辅酶Q10(CoQ10)及其他膳食组分 | |
JP2004518709A5 (zh) | ||
CN108201535A (zh) | 一种维利帕尼缓控释药物组合物及其用途 | |
EP3485876B1 (en) | Oral pharmaceutical composition and method for producing particulate formulation comprising composition | |
JP7428836B2 (ja) | 抗凝固薬の即時放出医薬製剤及びその調製方法 | |
CN101143142A (zh) | 水飞蓟宾过饱和自微乳组合物及其制备方法 | |
CN108420798A (zh) | 一种抗凝剂的速释药物制剂及其制备方法 | |
CN103655470A (zh) | 一种度他雄胺自微乳组合物及其制备方法 | |
CN102266292A (zh) | 骨架型双氯芬酸钾缓释微丸胶囊及其生产工艺 | |
CN102697764A (zh) | 一种含有异硫氰酸苯乙酯的肠溶固体制剂 | |
US20230201124A1 (en) | Lubricant for pharmaceuticals and nutraceuticals | |
CN102274274A (zh) | 可自微乳化的葛根黄酮口服微丸组合物及其制备方法 | |
CN106074385A (zh) | 一种沃替西汀自微乳制剂及其制备方法 | |
CN100335135C (zh) | 银杏叶提取物胶囊组合物及其制备方法 | |
JPH11269067A (ja) | ビタミンeとcを含有する速崩壊性錠剤 | |
CN105287428A (zh) | 一种鸦胆子油自乳化液体硬胶囊的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME: TIANJIN TIANSHILI PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Patentee after: Tasly Pharmaceutical Group Co., Ltd. Address before: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Patentee before: Tianjin Tianshili Pharmaceutical Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Patentee after: Tasly Pharmaceutical Group Limited by Share Ltd Address before: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Patentee before: Tasly Pharmaceutical Group Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder |